Evidence map›Paper›PMID 33437219›Full record

Observational studyInternational journal of medical sciences2021

Influence of

Laith N Al-Eitan, Ayah Y Almasri, Adan H Alnaamneh, Hatem A Aman, Nasr N Alrabadi, Rame H Khasawneh, Mansour A Alghamdi

Abstract readObservational Study
In one paragraph

Observational study in International journal of medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Pharmacogenomics Informs Cardiovascular Pharmacotherapy.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  7. Personalized medicine in cardiovascular disease: review of literature.Journal of diabetes and metabolic disorders · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laith N Al-EitanDepartment of Applied Biological Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan.
Ayah Y AlmasriDepartment of Applied Biological Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan.
Adan H AlnaamnehDepartment of Applied Biological Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan.
Hatem A AmanDepartment of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid 22110, Jordan.
Nasr N AlrabadiDepartment of Pharmacology, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
Rame H KhasawnehDepartment of Hematopathology, King Hussein Medical Center (KHMC), Royal Medical Services (RMS), Amman 11118, Jordan.
Mansour A AlghamdiDepartment of Anatomy, College of Medicine, King Khalid University, Abha 61421, Saudi Arabi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular diseases are among the leading causes of death worldwide. Many of those diseases require treatment with warfarin, an anticoagulant that has a large high inter and intra-variability in the required doses. The aim of this study is to find if there are any associations between rs2108622 of

Indexed as

Genetic Predisposition to DiseasePharmacogenomic VariantsAnticoagulantsApolipoproteins EAsian PeopleCardiovascular DiseasesCase-Control StudiesCytochrome P-450 CYP2A6Cytochrome P450 Family 4Dose-Response Relationship, DrugFollow-Up StudiesGene FrequencyHealthy VolunteersHumansInternational Normalized RatioJordanAnticoagulantsApoE protein, humanApolipoproteins ECYP2A6 protein, humanCYP4F2 protein, humanCytochrome P-450 CYP2A6Cytochrome P450 Family 4Warfarinand CYP2A6APOEcardiovascular diseaseCYP4F2Warfarin

Identifiers

PMID33437219
PMCPMC7797549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.